Gene · 10036
Papers2,603
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,603
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review. | Biomedicines | 2024 | 38275409 | PubTator, text mining | PubMed |
| A novel biomarker associated with EBV infection improves response prediction of immunotherapy in gastric cancer. | J Transl Med | 2024 | 38254099 | PubTator, text mining | PubMed |
| ATG14 targets lipid droplets and acts as an autophagic receptor for syntaxin18-regulated lipid droplet turnover. | Nat Commun | 2024 | 38245527 | PubTator, text mining | PubMed |
| Single-molecule imaging of stochastic interactions that drive dynein activation and cargo movement in cells. | J Cell Biol | 2024 | 38240798 | PubTator, text mining | PubMed |
| An oncogene regulating chromatin favors response to immunotherapy: Oncogene CHAF1A and immunotherapy outcomes. | Oncoimmunology | 2024 | 38235318 | PubTator, text mining | PubMed |
| The role of ADAR1 through and beyond its editing activity in cancer. | Cell Commun Signal | 2024 | 38233935 | PubTator, text mining | PubMed |
| Mutually exclusive teams-like patterns of gene regulation characterize phenotypic heterogeneity along the noradrenergic-mesenchymal axis in neuroblastoma. | Cancer Biol Ther | 2024 | 38230570 | PubTator, text mining | PubMed |
| N-acetyltransferase NAT10 controls cell fates via connecting mRNA cytidine acetylation to chromatin signaling. | Sci Adv | 2024 | 38215194 | PubTator, text mining | PubMed |
| miRNAs as predictive biomarkers of response to treatment in pediatric patients with acute lymphoblastic leukemia. | Oncol Lett | 2024 | 38192661 | PubTator, text mining | PubMed |
| ZSCAN4-binding motif-TGCACAC is conserved and enriched in CA/TG microsatellites in both mouse and human genomes. | DNA Res | 2024 | 38153767 | PubTator, text mining | PubMed |
| Inhibition of CAF-1 histone chaperone complex triggers cytosolic DNA and dsRNA sensing pathways and induces intrinsic immunity of hepatocellular carcinoma. | Hepatology | 2024 | 38051950 | PubTator, text mining | PubMed |
| Regulation of endogenous retroviruses in murine embryonic stem cells and early embryos. | J Mol Cell Biol | 2024 | 37604781 | PubTator, text mining | PubMed |
| Quantification of AMPA receptor subunits and RNA editing-related proteins in the J20 mouse model of Alzheimer's disease by capillary western blotting. | Front Mol Neurosci | 2023 | 38299128 | PubTator, text mining | PubMed |
| Identification of a novel B-cell epitope of the African swine fever virus p34 protein and development of an indirect ELISA for the detection of serum antibodies. | Front Microbiol | 2023 | 38282734 | PubTator, text mining | PubMed |
| Emerging insights into keratin 7 roles in tumor progression and metastasis of cancers. | Front Oncol | 2023 | 38260844 | PubTator, text mining | PubMed |
| Identification of the p34 Protein of African Swine Fever Virus as a Novel Viral Antigen with Protection Potential. | Viruses | 2023 | 38257738 | PubTator, text mining | PubMed |
| Potential applications of JAK inhibitors, clinically approved drugs against autoimmune diseases, in cancer therapy. | Front Pharmacol | 2023 | 38235120 | PubTator, text mining | PubMed |
| PNLDC1 catalysis and postnatal germline function are required for piRNA trimming, LINE1 silencing, and spermatogenesis in mice. | bioRxiv | 2023 | 38234819 | PubTator, text mining | PubMed |
| Harnessing ADAR-Mediated Site-Specific RNA Editing in Immune-Related Disease: Prediction and Therapeutic Implications. | Int J Mol Sci | 2023 | 38203521 | PubTator, text mining | PubMed |
| A methylation-related signature for predicting prognosis and sensitivity to first-line therapies in gastric cancer. | J Gastrointest Oncol | 2023 | 38196539 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10036/papers?page=5